Similar articles

• Evidence-based guidelines on the use of intravenous immune globulin for hematologic and neurologic conditions.

  Robinson P, Anderson D, Brouwers M, Feasby TE, Hume H; IVIG Hematology and Neurology Expert Panels. Robinson P, et al. Transfus Med Rev. 2007 Apr;21(2 Suppl 1):S3-8. doi: 10.1016/j.tmrv.2007.01.004. Transfus Med Rev. 2007. PMID: 17397767
• Guidelines on the use of intravenous immune globulin for hematologic conditions.

  Anderson D, Ali K, Blanchette V, Brouwers M, Couban S, Radmoor P, Huebsch L, Hume H, McLeod A, Meyer R, Moltzan C, Nahirniak S, Nantel S, Pineo G, Rock G. Anderson D, et al. Transfus Med Rev. 2007 Apr;21(2 Suppl 1):S9-56. doi: 10.1016/j.tmrv.2007.01.001. Transfus Med Rev. 2007. PMID: 17397769
• Guidelines on the use of intravenous immune globulin for neurologic conditions.

  Feasby T, Banwell B, Benstead T, Bril V, Brouwers M, Freedman M, Hahn A, Hume H, Freedman J, Pi D, Wadsworth L. Feasby T, et al. Transfus Med Rev. 2007 Apr;21(2 Suppl 1):S57-107. doi: 10.1016/j.tmrv.2007.01.002. Transfus Med Rev. 2007. PMID: 17397768
• Current clinical uses of intravenous immunoglobulin.

  El-Shanawany T, Sewell WA, Misbah SA, Jolles S. El-Shanawany T, et al. Clin Med (Lond). 2006 Jul-Aug;6(4):356-9. doi: 10.7861/clinmedicine.6-4-356. Clin Med (Lond). 2006. PMID: 16956140 Free PMC article. Review. No abstract available.
• [Use of immunoglobulin in the therapy of neurological illnesses].

  Elovaara I, Färkkilä M, Hietaharju A, Pirttilä T. Elovaara I, et al. Duodecim. 2001;117(10):1033-41; quiz 1041, 1081. Duodecim. 2001. PMID: 12116461 Review. Finnish. No abstract available.